Prediabetic State Clinical Trial
Official title:
Effects of Clinical Pilates Exercises on Glycemic Control, Blood Lipids and Physical Fitness Parameters in Individuals With Prediabetes: Controlled Study
NCT number | NCT06452940 |
Other study ID # | AKaraman |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | May 15, 2024 |
Est. completion date | February 2025 |
To examine the effects of clinical pilates exercise on glycemic control, blood lipids and physical fitness parameters in prediabetics. Subjects will be divided into two groups through randomization.Subjects in the 1st group will be included in the control group and will continue their routine. Subjects in the 2nd group will be given clinical pilates exercise training. All subjects will be evaluated at the start of treatment, and week 16.
Status | Recruiting |
Enrollment | 42 |
Est. completion date | February 2025 |
Est. primary completion date | September 15, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 30 Years to 60 Years |
Eligibility | Inclusion Criteria: - Being diagnosed with Prediabetes - Being between the ages of 30-60 - Not having received physiotherapy in the last 6 months - Being physically inactive (<150 min/week or <600 MET/week according to the International Physical Activity Survey Short Version) Exclusion Criteria: - Having a history of type 2 diabetes - Taking any supplements to maintain weight control - Having a history of acute trauma affecting the movement system within the last month - Presence of orthopedic/neurological/cardiopulmonary disease affecting the movement system - Pregnancy |
Country | Name | City | State |
---|---|---|---|
Turkey | Eastern Mediterranean University | Mersin | Famagusta |
Lead Sponsor | Collaborator |
---|---|
Eastern Mediterranean University |
Turkey,
ADA(Am.DiabetesAssoc.).2020.2.Classificationanddiagnosisofdiabetes:StandardsofMedicalCare in Diabetes-2020. Diabetes Care 43(Suppl. 1):S14-31
Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health. 2021 Apr 1;42:59-77. doi: 10.1146/annurev-publhealth-090419-102644. Epub 2021 Dec 23. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The glycosylated hemoglobin A1c | An A1C test result reflects your average blood sugar level for the past two to three months. Specifically, the A1C test measures what percentage of hemoglobin proteins in your blood are coated with sugar (glycated). Hemoglobin proteins in red blood cells transport oxygen.
The higher your A1C level is, the poorer your blood sugar control and the higher your risk of diabetes complications. |
at baseline and at the end of the 16th week | |
Secondary | Fasting Blood Glucose | The expected values for normal fasting blood glucose concentration are between 70 mg/dL (3.9 mmol/L) and 100 mg/dL (5.6 mmol/L). When fasting blood glucose is between 100 to 125 mg/dL (5.6 to 6.9 mmol/L) changes in lifestyle and monitoring glycemia are recommended. | at baseline and at the end of the 16th week | |
Secondary | Fasting insulin | Fasting insulin value will be checked based on blood analyses performed during routine doctor controls. | at baseline and at the end of the 16th week | |
Secondary | HOMA-IR | HOMA-IR value will be checked based on blood analyses performed during routine doctor controls. | at baseline and at the end of the 16th week | |
Secondary | HDL, LDL | values will be checked based on blood analyses performed during routine doctor controls. | at baseline and at the end of the 16th week | |
Secondary | Vitamin D | Vitamin D, value will be checked based on blood analyses performed during routine doctor controls. | at baseline and at the end of the 16th week | |
Secondary | Triglyceride | Triglyceride, value will be checked based on blood analyses performed during routine doctor controls. | at baseline and at the end of the 16th week | |
Secondary | Total cholesterol | Total cholesterol, value will be checked based on blood analyses performed during routine doctor controls. | at baseline and at the end of the 16th week | |
Secondary | Body composition measurement | Weight, body fat percentage, total body water, fat mass, fat mass, lean body mass will be measured with a bioelectrical impedance analyzer. | at baseline and at the end of the 16th week | |
Secondary | Waist-hip ratio | Waist and hip circumference will be measured with a tape measure and waist/hip ratio will be calculated. | at baseline and at the end of the 16th week | |
Secondary | Grip Strength | Grip strength will be measured with a hand-grip dynamometer. The patient will be asked to sit with his/her back straight and grasp and squeeze the dynamometer with the dominant side hand. The best value will be recorded by repeating three times | at baseline and at the end of the 16th week | |
Secondary | Muscle Strength | Muscle strength of the upper and lower extremity muscles will be measured using a digital hand-held dynamometer. In order to ensure that the movement is correctly revealed in the measurements, the individuals will be asked to perform submaximal contraction against the evaluator's hand and the evaluation will be started after the test trial is performed. The best value will be recorded after three repetitions | at baseline and at the end of the 16th week | |
Secondary | Functional Strength of Core Muscles | Sit-ups and modified push-up tests will be performed. Measurements will be made using a stopwatch and the number of repetitions performed by individuals within 30 seconds will be recorded | at baseline and at the end of the 16th week | |
Secondary | Sit-up Test | Sit-up tests will be performed for the functional strength of core muscles. Measurements will be made using a stopwatch and the number of repetitions performed by individuals within 30 seconds will be recorded | at baseline and at the end of the 16th week | |
Secondary | Modified push-up Test | Modified push-up tests will be performed for functional strength of core muscles. Measurements will be made using a stopwatch and the number of repetitions performed by individuals within 30 seconds will be recorded | at baseline and at the end of the 16th week | |
Secondary | Lower Extremity Endurance | A 30-second sit and stand test will be performed to assess lower extremity endurance.
McGill protocol will be applied to evaluate core endurance. This protocol includes trunk flexion, lateral bridge, modified "Biering-sorensen", prone bridge tests.Tests will be terminated when the positions are disturbed. The measurement results will be recorded in seconds. |
at baseline and at the end of the 16th week | |
Secondary | Core Endurance | McGill protocol will be applied to evaluate core endurance. This protocol includes trunk flexion, lateral bridge, modified "Biering-sorensen", prone bridge tests.Tests will be terminated when the positions are disturbed. The measurement results will be recorded in seconds. | at baseline and at the end of the 16th week | |
Secondary | Sit-Reach Test | SRT will be performed for flexibility. The test will be repeated three times and the highest value will be recorded. | at baseline and at the end of the 16th week | |
Secondary | Lateral Flexion Test | LFT will be performed for flexibility.The test will be repeated three times and the highest value will be recorded. | at baseline and at the end of the 16th week | |
Secondary | Balance | The Fullerton advanced balance (FAB-T) scale will be used. | at baseline and at the end of the 16th week | |
Secondary | Exercise Beliefs | Exercise beliefs will be assessed with the exercise benefits/barriers scale. | at baseline and at the end of the 16th week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05424107 -
A Mediterranean Intervention on Prediabetic Children
|
N/A | |
Recruiting |
NCT02681887 -
Effect of Melatonin on Cardiometabolic Risk- FULL
|
Phase 3 | |
Completed |
NCT04088461 -
Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine
|
Phase 4 | |
Recruiting |
NCT02561377 -
Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics)
|
N/A | |
Completed |
NCT02678390 -
Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes
|
N/A | |
Completed |
NCT02551640 -
Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients
|
N/A | |
Completed |
NCT02459691 -
Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos)
|
N/A | |
Completed |
NCT01479933 -
Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes
|
N/A | |
Completed |
NCT01671293 -
Multicomponent Telecare Model for Supporting Prediabetes Patients
|
N/A | |
Completed |
NCT00960973 -
The Effect of Vitamin K Supplementation on Glucose Metabolism
|
Phase 4 | |
Completed |
NCT00455325 -
Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
|
Phase 2 | |
Recruiting |
NCT05123963 -
Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors
|
N/A | |
Recruiting |
NCT05340868 -
Genetics of the Acute Response to Oral Semaglutide
|
N/A | |
Recruiting |
NCT04984421 -
IMplementation of the Family Support PRogramme A Healthy School Start to Prevent OVErweight and Obesity (IMPROVE)
|
N/A | |
Recruiting |
NCT04131582 -
Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes
|
Phase 3 | |
Recruiting |
NCT04134650 -
Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes
|
Phase 3 | |
Recruiting |
NCT05347030 -
Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population
|
N/A | |
Completed |
NCT04074148 -
Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal
|
N/A | |
Recruiting |
NCT05050266 -
Enhancing Mental and Physical Health of Women Veterans
|
N/A | |
Completed |
NCT02684565 -
Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects
|
N/A |